Does the presence of interstitial lung disease affect your decision to offer SBRT for early stage NSCLC?
Specifically in O2-dependent patients? Have any dose/fractionation regimens been shown to reduce the risk of pneumonitis in this population?
Answer from: Radiation Oncologist at Academic Institution
As opposed to interstitial lung disease (ILD) in general, the entity most described in the literature as associated with severe pulmonary toxicity after SABR has more specifically been idiopathic pulmonary fibrosis (IPF) and additionally, in the absence of a known diagnosis of IPF, CT findings consi...
Answer from: Radiation Oncologist at Academic Institution
Over the years, I have become more conservative and cautious in my utilization of radiation therapy (both conventional and SBRT) in patients with known interstitial lung disease (ILD) and will refer patients to a pulmonologist if incidental findings of interstitial fibrosis are noted on CT imaging, ...
Comments
Radiation Oncologist at National Cancer Institute Can you please clarify what you meant by “smallâ...
Radiation Oncologist at Stanford University School of Medicine As opposed to interstitial lung disease (ILD) in g...